Display options
Share it on

Respir Med Case Rep. 2015 Sep 21;16:125-7. doi: 10.1016/j.rmcr.2015.09.009. eCollection 2015.

Effect of enterovirus D68 on Lung Clearance Index in patients with cystic fibrosis: A case report.

Respiratory medicine case reports

Danielle M Goetz, Shipra Singh, Daniel Sheehan

Affiliations

  1. Department of Pediatrics, University at Buffalo, State University of New York, USA.

PMID: 26744677 PMCID: PMC4681970 DOI: 10.1016/j.rmcr.2015.09.009

Abstract

Cystic fibrosis (CF) causes airways obstruction and a decline in percent predicted forced expiratory volume in 1 s (FEV1%). FEV1% is an objective measure of a pulmonary exacerbation of CF; improvement in FEV1% is the endpoint used often to determine success of treatment of these acute declines in pulmonary health. Lung Clearance Index (LCI), derived from multiple breath inert gas washout (MBW) test, measures ventilation inhomogeneity and small airways dysfunction. In the United States in 2014-2015, enterovirus D68 (EV-D68), a novel virus, led to hospitalizations in children because of respiratory distress. This report describes 2 patients with CF admitted for pulmonary exacerbations who were enrolled in an inpatient study to assess patient satisfaction and utility of MBW to measure LCI. Diagnostic testing indicated that these patients were infected with EV-D68. Although their FEV1% improved to their previous baseline following treatment for pulmonary exacerbation, it was discordant with LCI. We discuss LCI as a novel measure of pulmonary function and hypothesize that, based on these cases, it may be a more sensitive indicator of ongoing post-viral airways dysfunction as compared to FEV1%.

Keywords: CF, Cystic Fibrosis; Cystic fibrosis; EV-D68, Enterovirus D68; Enterovirus D68; FEF 25−75%, Percent predicted forced expiratory flow in mid-range; FEV1%, Percent predicted forced expiratory volume in one second; LCI, Lung Clearance Index; Lung Clearance Index; MBW, Multiple breath inert gas washout; Multiple breath washout; RT-PCR, Reverse transcription polymerase chain reaction; Viral infection

References

  1. J Cyst Fibros. 2005 Aug;4 Suppl 2:31-6 - PubMed
  2. J Cyst Fibros. 2014 Mar;13(2):123-38 - PubMed
  3. Pediatrics. 2008 Dec;122(6):1171-6 - PubMed
  4. Curr Opin Pulm Med. 2012 May;18(3):271-8 - PubMed
  5. Eur Respir J. 2004 Jan;23 (1):93-7 - PubMed
  6. Am J Respir Crit Care Med. 2005 Feb 1;171(3):249-56 - PubMed
  7. Pediatr Infect Dis J. 2005 Nov;24(11 Suppl):S159-69, discussion S166-7 - PubMed
  8. Thorax. 2016 Mar;71(3):223-9 - PubMed
  9. Ther Adv Infect Dis. 2013 Aug;1(4):139-50 - PubMed
  10. Eur Respir J. 2015 Oct;46(4):1055-64 - PubMed
  11. Pediatr Pulmonol. 1993 Feb;15(2):75-88 - PubMed
  12. J Clin Virol. 2014 Jun;60(2):147-53 - PubMed
  13. Thorax. 2014 Jan;69(1):39-45 - PubMed

Publication Types